What Does the Future of Phase III Clinical Trials Look Like in a Population Health Model

As the population health framework transforms the way clinical care is delivered to individuals and communities, it is expected to influence research agendas and broaden the scope of information available for clinical research. This article provides insight on how the shift toward population health will impact Phase III trials. The findings were derived through an expert panel discussion, involving an evidence review and survey of stakeholders with backgrounds in population health and clinical trials. Overall, there was consensus that the population health framework will have an impact on the future of Phase III clinical trials, and that researchers have an opportunity to incorporate these concepts to evolve the clinical trial model. In particular, there are promising trends related to technology and data.